| Literature DB >> 30904813 |
Pravien Rajaram1, Ziran Jiang1, Guanglin Chen1, Alyssa Rivera1, Alison Phasakda1, Qiang Zhang2, Shilong Zheng2, Guangdi Wang2, Qiao-Hong Chen3.
Abstract
Forty-eight nitrogen-containing quercetin derivatives were synthesized from readily available rutin or quercetin for the in vitro evaluation of their biological profiles. The WST-1 cell proliferation assay data indicate that thirty-nine out of the forty-eight derivatives possess significantly improved antiproliferative potency as compared with quercetin and fisetin, as well as the parent 3,3',4',7-O-tetramethylquercetin toward both androgen-sensitive (LNCaP) and androgen-insensitive (PC-3 and DU145) human prostate cancer cell lines. 5-O-Aminoalkyl-3,3',4',7-O-tetramethylquercetins were established as a better scaffold for further development as anti-prostate cancer agents. Among them, 5-O-(N,N-dibutylamino)propyl-3,3',4',7-O-tetramethylquercetin (44) was identified as the optimal derivative with IC50 values of 0.55-2.82 µM, being over 35-182 times more potent than quercetin. The flow cytometry-based assays further demonstrate that 44 effectively activates PC-3 cell apoptosis.Entities:
Keywords: Antiproliferative activity; Cell apoptosis; Prostate cancer; Quercetin derivative; Synthesis
Year: 2019 PMID: 30904813 PMCID: PMC6538460 DOI: 10.1016/j.bioorg.2019.03.047
Source DB: PubMed Journal: Bioorg Chem ISSN: 0045-2068 Impact factor: 5.275